立即開始
做多

ATNF | Is My Math Off? | LONG

547
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
DivergenceSeeker
99% of the market trades the noise. I trade the math. Professional divergence hunter and volume tracker. Enter the Seeker Lab:

linktr.ee/DivergenceSeeker
此外:
biotechnologyBullish DivergencehealthcareTechnical Indicatorsoversold

免責聲明

這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
biotechnologyBullish DivergencehealthcareTechnical Indicatorsoversold
DivergenceSeeker
99% of the market trades the noise. I trade the math. Professional divergence hunter and volume tracker. Enter the Seeker Lab:

linktr.ee/DivergenceSeeker
此外:

免責聲明

這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。